Diabetes drug may melt heart fat and boost cardiac function
NCT ID NCT02042664
First seen May 10, 2026 · Last updated Jun 12, 2026 · Updated 9 times
Summary
This study looked at whether a class of diabetes drugs called GLP-1 receptor agonists can improve heart function and reduce fat around the heart in obese people with type 2 diabetes. The researchers measured heart fat and function using MRI scans in 44 participants. The goal was to see if these drugs, which lower blood sugar and promote weight loss, also have direct benefits for the heart.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Assistance Publique Hopitaux de Marseille
Marseille, 13354, France
Conditions
Explore the condition pages connected to this study.